Kriya Therapeutics, Inc.
Clinical trials sponsored by Kriya Therapeutics, Inc., explained in plain language.
-
Gene therapy aims to free type 1 diabetics from insulin shots
Cure Not yet recruitingResearchers are testing two experimental gene therapies, VV-14299 and VV-14300, in adults with long-standing type 1 diabetes whose blood sugar remains poorly controlled despite using an automated insulin pump. The therapies are injected into muscle and are designed to work togeth…
Phase 1/2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Cure
Last updated Sep 21, 2026 19:00 UTC
-
Muscle-Injected gene therapy aims to help type 1 diabetes control blood sugar
Cure Not yet recruitingResearchers are testing a gene therapy called VV-14300 in adults with long-standing type 1 diabetes whose blood sugar remains poorly controlled despite using an automated insulin delivery system. The therapy uses a harmless virus to deliver the glucokinase gene into muscle, where…
Phase 1/2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Cure
Last updated Sep 21, 2026 19:00 UTC